TherapeuticsMD (TXMD) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.93, -2.03% vs the prior close of $1.97.
- Volume 18.00K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TXMD dips 2.0% to $1.93, a 3-month low. Closed at $1.93, -2.03% vs the prior close of $1.97. Day range $1.92–$1.98, opened at $1.97.
TXMD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — TXMD dips 2.0% to $1.93, a 3-month low
- Closed at $1.93, -2.03% vs the prior close of $1.97. Day range $1.92–$1.98, opened at $1.97.
- Volume was 18.00K shares, 0.7x its 50-day average of 24.39K.
- Price is -8.1% vs its 50-day average ($2.10) and -9.0% vs its 200-day average ($2.12).
- 52-week range $1.03–$2.95; today's close sits at 47% of that range, 34.6% below the 52-week high.
Oct 14, 2026 — TXMD rises 0.5% to $1.97
- Closed at $1.97, +0.51% vs the prior close of $1.96. Day range $1.96–$1.99, opened at $1.96.
- Volume was 6.90K shares, 0.3x its 50-day average of 24.71K — lighter than usual.
- Price is -6.4% vs its 50-day average ($2.10) and -7.1% vs its 200-day average ($2.12).
- 52-week range $1.03–$2.95; today's close sits at 49% of that range, 33.2% below the 52-week high.
Oct 13, 2026 — TXMD dips 3.0% to $1.96, a 1-month low
- Closed at $1.96, -2.97% vs the prior close of $2.02. Day range $1.96–$1.99, opened at $1.99.
- Volume was 29.10K shares, 1.2x its 50-day average of 24.44K.
- Price is -6.9% vs its 50-day average ($2.11) and -7.5% vs its 200-day average ($2.12).
- 52-week range $1.03–$2.95; today's close sits at 48% of that range, 33.6% below the 52-week high.
Oct 12, 2026 — TXMD dips 1.9% to $2.02
- Closed at $2.02, -1.94% vs the prior close of $2.06. Day range $2.00–$2.05, opened at $2.01.
- Volume was 14.00K shares, 0.6x its 50-day average of 24.35K — lighter than usual.
- Price is -4.1% vs its 50-day average ($2.11) and -4.6% vs its 200-day average ($2.12).
- 52-week range $1.03–$2.95; today's close sits at 52% of that range, 31.5% below the 52-week high.
Oct 9, 2026 — TXMD rises 2.5% to $2.06
- Closed at $2.06, +2.49% vs the prior close of $2.01. Day range $1.99–$2.06, opened at $2.00.
- Volume was 10.10K shares, 0.4x its 50-day average of 24.43K — lighter than usual.
- Price is -2.2% vs its 50-day average ($2.11) and -2.7% vs its 200-day average ($2.12).
- 52-week range $1.03–$2.95; today's close sits at 54% of that range, 30.2% below the 52-week high.
Oct 8, 2026 — TXMD rises 0.5% to $2.01
- Closed at $2.01, +0.50% vs the prior close of $2.00. Day range $1.99–$2.03, opened at $2.00.
- Volume was 13.80K shares, 0.6x its 50-day average of 24.60K — lighter than usual.
- Price is -4.6% vs its 50-day average ($2.11) and -4.9% vs its 200-day average ($2.11).
- 52-week range $1.03–$2.95; today's close sits at 51% of that range, 31.9% below the 52-week high.
Oct 7, 2026 — TXMD dips 1.0% to $2.00, a 1-month low
- Closed at $2.00, -0.99% vs the prior close of $2.02. Day range $1.99–$2.04, opened at $2.00.
- Volume was 42.50K shares, 1.8x its 50-day average of 24.07K.
- Price is -5.1% vs its 50-day average ($2.11) and -5.3% vs its 200-day average ($2.11).
- 52-week range $1.03–$2.95; today's close sits at 51% of that range, 32.2% below the 52-week high.
Oct 6, 2026 — TXMD rises 0.5% to $2.02
- Closed at $2.02, +0.50% vs the prior close of $2.01. Day range $2.01–$2.06, opened at $2.01.
- Volume was 8.40K shares, 0.3x its 50-day average of 24.10K — lighter than usual.
- Price is -4.2% vs its 50-day average ($2.11) and -4.3% vs its 200-day average ($2.11).
- 52-week range $0.99–$2.95; today's close sits at 53% of that range, 31.5% below the 52-week high.
Oct 5, 2026 — TXMD dips 2.0% to $2.01, a 1-month low
- Closed at $2.01, -1.95% vs the prior close of $2.05. Day range $2.01–$2.08, opened at $2.02.
- Volume was 19.40K shares, 0.8x its 50-day average of 24.33K.
- Price is -4.7% vs its 50-day average ($2.11) and -4.7% vs its 200-day average ($2.11).
- 52-week range $0.99–$2.95; today's close sits at 52% of that range, 31.9% below the 52-week high.
Oct 2, 2026 — TXMD rises 1.0% to $2.05
- Closed at $2.05, +0.99% vs the prior close of $2.03. Day range $2.00–$2.06, opened at $2.00.
- Volume was 9.90K shares, 0.4x its 50-day average of 24.68K — lighter than usual.
- Price is -2.9% vs its 50-day average ($2.11) and -2.7% vs its 200-day average ($2.11).
- 52-week range $0.99–$2.95; today's close sits at 54% of that range, 30.5% below the 52-week high.
TXMD latest news & SEC filings
Every SEC filing by or about TXMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $155.00K (prior year $551.00K) (-71.9% vs Jun 30, 2025)
- Diluted EPS: $0.01 (prior year $0.05) (-80.0% vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 5, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade TXMD
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 30, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.66% (largest 4.1%).
- Liquidity: about 17.41K shares (≈$33.61K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.93 vs a range of $1.03–$2.95 (47% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 0 sales; latest: Tommy G Thompson bought 8,400 shares on Dec 23, 2025.
- Latest filings: 10-Q Aug 11, 2026; 8-K Aug 11, 2026; 10-Q May 12, 2026.
- Share count: 11.57M shares outstanding (Aug 9, 2026), +0.0% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
TXMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.97 | 1.98 | 1.92 | 1.93 | 18.00K |
| Oct 14, 2026 | 1.96 | 1.99 | 1.96 | 1.97 | 6.90K |
| Oct 13, 2026 | 1.99 | 1.99 | 1.96 | 1.96 | 29.10K |
| Oct 12, 2026 | 2.01 | 2.05 | 2.00 | 2.02 | 14.00K |
| Oct 9, 2026 | 2.00 | 2.06 | 1.99 | 2.06 | 10.10K |
| Oct 8, 2026 | 2.00 | 2.03 | 1.99 | 2.01 | 13.80K |
| Oct 7, 2026 | 2.00 | 2.04 | 1.99 | 2.00 | 42.50K |
| Oct 6, 2026 | 2.01 | 2.06 | 2.01 | 2.02 | 8.40K |
| Oct 5, 2026 | 2.02 | 2.08 | 2.01 | 2.01 | 19.40K |
| Oct 2, 2026 | 2.00 | 2.06 | 2.00 | 2.05 | 9.90K |
| Oct 1, 2026 | 2.02 | 2.06 | 2.00 | 2.03 | 20.40K |
| Sep 30, 2026 | 2.10 | 2.12 | 2.03 | 2.03 | 7.20K |
| Sep 29, 2026 | 2.10 | 2.10 | 2.04 | 2.04 | 8.00K |
| Sep 28, 2026 | 2.03 | 2.09 | 2.03 | 2.09 | 12.10K |
| Sep 25, 2026 | 2.13 | 2.13 | 2.04 | 2.05 | 13.80K |
| Sep 24, 2026 | 2.10 | 2.16 | 2.10 | 2.13 | 7.40K |
| Sep 23, 2026 | 2.17 | 2.20 | 2.11 | 2.17 | 29.80K |
| Sep 22, 2026 | 2.08 | 2.17 | 2.08 | 2.16 | 17.20K |
| Sep 21, 2026 | 2.18 | 2.19 | 2.04 | 2.10 | 52.30K |
| Sep 18, 2026 | 2.19 | 2.19 | 2.18 | 2.19 | 8.00K |
About TherapeuticsMD
TherapeuticsMD (TXMD) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BOCA RATON, FL. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 25743.
TXMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Cooper C. Collins | Director | Nov 5, 2025 |
| Gail K Naughton | Director | Nov 5, 2025 |
| Tommy G Thompson | Director | Dec 29, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Marlan D Walker | Chief Executive Officer | Nov 5, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 23, 2025 | Tommy G Thompson | Buy | 8,400 | $1.67 |
TXMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-569.00K | -0.05 | — |
| Dec 31, 2024 | — | $-2.18M | -0.19 | — |
| Dec 31, 2023 | — | $-10.28M | -0.99 | — |
| Dec 31, 2022 | $69.96M | $112.00M | 11.96 | — |
| Dec 31, 2021 | $2.57M | $-172.41M | -21.66 | $-142.69M |
Latest balance sheet: total assets $37.53M, total liabilities $10.40M, cash $5.75M (as of Jun 30, 2026).
TXMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $2.07 |
| May 12, 2026 | 8-K Item 2.02 (results) | $1.95 |
| Mar 30, 2026 | 8-K Item 2.02 (results) | $1.99 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $1.62 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $1.11 |
| May 13, 2025 | 8-K Item 2.02 (results) | $1.52 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $1.05 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $1.50 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 10, 2024 | 8-K Item 2.02 (results) | — |
| Mar 29, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on TXMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.